Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
81 participants
OBSERVATIONAL
2022-08-08
2026-08-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Meaning Centered Psychotherapy for Palliative Care Patients (MCP-PC)
NCT03612050
Meaning-Centered Psychotherapy Training for Cancer Care Providers
NCT02730039
Easing Psychosocial Burden for Informal Caregivers
NCT03454295
Problem-Solving Therapy for Cancer Caregivers in Outpatient Palliative Care
NCT04867122
A Study of Meaning-Centered Psychotherapy for Caregivers to People With Cancer
NCT06307535
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phase 1: Nurse Participants
n=8-10 nurses
Meaning-Centered Psychotherapy/MCP-PC Training
Two-Day MCP-PC Training for Nurses (including mock patient/simulation with actor) with a Pre- and Post-Training Assessment
Phase 1: Patient Participants
n=8-10 patients
Meaning-Centered Psychotherapy/MCP-PC
3 sessions, completed over the course of 3-6 weeks in the participant's home
Phase 2: Nurse Participants
n=8-10 nurses
Meaning-Centered Psychotherapy/MCP-PC Training
Two-Day MCP-PC Training for Nurses (including mock patient/simulation with actor) with a Pre- and Post-Training Assessment
Phase 2: Patient Participants Meaning-Centered Psychotherapy/MCP-PC Intervention Arm
n=35
Meaning-Centered Psychotherapy/MCP-PC
3 sessions, completed over the course of 3-6 weeks in the participant's home
Phase 2: Patient Participants Treatment As Usual/TAU Intervention Arm
n=35
Treatment As Usual/TAU
Research team will provide:
1. feedback about level of distress at time of screening
2. local referral for psychological care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Meaning-Centered Psychotherapy/MCP-PC Training
Two-Day MCP-PC Training for Nurses (including mock patient/simulation with actor) with a Pre- and Post-Training Assessment
Meaning-Centered Psychotherapy/MCP-PC
3 sessions, completed over the course of 3-6 weeks in the participant's home
Treatment As Usual/TAU
Research team will provide:
1. feedback about level of distress at time of screening
2. local referral for psychological care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Per self-report, providing direct care services at VNS Health
* Per self-report, fluent in English\*\*
* Per self-report, is age 18 or older
Patients (all phases):
* Per health record and/or self-report, is a patient in the VNS Health home health agency division (post-acute care)
* Per health record and/or self-report, is age 18 or older
* Per health record, has a cancer diagnosis and a rating of ≥ 2 on Symptom Control Scale
* Per health record and/or self-report, fluent in English\*\*
* Has a score of ≥ 4 on Callahan cognitive screener
* Has a score of ≥ 4 on Distress Thermometer (N/A for Training Case Participants)
* Language verification: For both nurses and patients, prior to enrollment, all will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify
English fluency necessary for participation in the study:
1. How well do you speak English? (must respond "very well" or "well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused)
2. What is your preferred language for healthcare? (must respond English)
Exclusion Criteria
* Per self-report, planning to leave position at VNS Health in the next 6 months
Patients (all phases):
* Per health record and/or self-report, has a diagnosis of Alzheimer's, dementia, or other organic brain disorder and in the judgment of the PIs is unable to meaningfully participate.
* Per health record, has impaired decision-making capacity
* Per health record and/or self-report, is permanently placed in a nursing home
* Per health record and/or self-report, is currently receiving Hospice care
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rebecca Saracina, PhD
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Visiting Nurse Service of NY
New York, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Saracino RM, Park EY, Onorato N, Pessin H, McDonald M, Demirjian C, Schofield E, Rosenfeld B, Breitbart W, Applebaum AJ. A pragmatic randomized controlled trial of nurse-delivered brief Meaning Centered Psychotherapy at Home (MCP-H) for individuals with advanced cancer: Study protocol. J Geriatr Oncol. 2025 Oct 3;16(8):102736. doi: 10.1016/j.jgo.2025.102736. Online ahead of print.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.